Tue, 20 May 2014
In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT). |
Tue, 6 May 2014
In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis). |